Vivro Financial Services Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement for the attention of the Public Shareholders of Shree Pacetronix Ltd ("Target ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.3 pts more than Nifty Microcap 250 and 8.2 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shree Pacetronix Ltd (BSE: 527005) is the subject of a mandatory Open Offer by its existing promoter group — Akash Sethi (Acquirer) along with PACs Atul Kumar Sethi, Amita Sethi, and Ashish Sethi. The open offer is for up to 9,75,000 equity shares (26% of Expanded Share Capital) at Rs 100 per share, aggregating to Rs 9.75 crore assuming full acceptance. The offer is triggered under SEBI (SAST) Regulations 3(1) and 3(3) following a Securities Subscription Agreement (SSA) dated August 7, 2025, under which the target company will preferentially allot 75,150 equity shares, 75,150 Series A warrants, and 1,50,300 Series B warrants to the Acquirer at Rs 81 per share. The promoter group's holding will rise from 24.25% to 30.09% post-preferential issue, and up to 55.09% if the full 26% open offer is tendered. The offer is not a delisting proposal.
This is a promoter-led equity infusion rather than a third-party takeover — existing promoters are increasing their stake via preferential warrants and a mandatory open offer. Short-term stock price may react around the offer mechanics and warrant conversion timelines. Public shareholders can tender shares at Rs 100 or choose to remain invested as the promoters have stated intent to retain the company’s listing status.